OCC 1.25% 39.5¢ orthocell limited

rise on volume, page-15

  1. 9,081 Posts.
    I don't think it's an accident that this buying surge has coincided with all of the market negativity linked to the crisis in Greece. Nervous sellers have delivered OCC stock into eager strong hands. They are not getting mine. This stock is a keeper and is in the vanguard of regenerative medicine. It already has sales, patents, partners, approvals and a plethora of exciting developments in the pipeline. This one could easily transform quite quickly into a significant regenerative medicine stock. They have even successfully grown in the lab human tendons. Watch this space!
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.